Privacy concerns that emerged since law enforcement started mining the databases have put such a serious dent in the business that both Ancestry.com and 23andMe have reduced employees significantly.
Academic rigour, journalistic flair
Articles on 23andMe
Displaying all articles
When DNA databases and behavioural genetics combine, your family's genes could play a role in criminal sentencing
DNA testing kits will be a popular gift this holiday season. Before mailing off your saliva, it’s important to understand what these kits can and cannot tell us.
A US judge has allowed police access to the major DNA database without users' consent (including Australian users). It's a timely reminder that we urgently need genetic privacy legislation.
Scientists explain why commercial gene testing should be used with caution.
Genetic testing companies are offering tests that analyze the ends of your chromosomes – telomeres – to gauge your health and your real age. But is there scientific evidence to support such tests?
New research investigated who uses the wide array of tools available to people who've received their own raw genetic data and want to maximize what they learn from it.
Direct-to-consumer genetic testing company 23andMe is now offering a new 'polygenic risk score' that reveals your risk of developing Type 2 diabetes. Does it work? Are our family physicians ready?
When you share your genetic data – even with the NHS – you don't know where it will end up, or how it will be used.
Researchers find 351 genetic variants associated with a person's chronotype. Before this study, we knew of only 24.
Alzheimer's is not only the third leading cause of death in the U.S. but also the most dreaded diagnosis. Genetic testing can help determine susceptibility, but knowing whether to test isn't easy.
Data and privacy issues are tangled up in the DNA reports consumers get from big genetic testing companies – and the third-party sites they turn to in order to glean more from their raw DNA.
More people are sending off saliva samples to find out about their genetic roots. But the raw DNA results go way beyond genealogical data – and could deliver unintended consequences.
A genetics testing company recently won approval from the FDA to market a test that can identify a breast cancer gene mutation. But what are women supposed to do with that information? There's risk involved.
The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone…
Genetic testing is a powerful tool. Two years ago, with the help of my colleagues, it was this tool that helped us identify a new disease. The disease, called Ogden Syndrome, caused the death of a four-month…
Job Board
-
Research Fellow
-
Senior Lecturer in Nursing
-
DIGITAL PRODUCT OWNER
-
Senior Lecturer in Management
-
Head of Patient Programs
Top contributors
-
Research Scientist in Biostatistics, University of Washington
-
Assistant Professor in Human Genetics, Cold Spring Harbor Laboratory
-
Research Professor of Epidemiology, Emory University
-
Adjunct Lecturer in Law, University of Sydney
-
Postdoctoral research associate, University of Sydney
-
Professor of Biology, Boise State University
-
Junior Fellow, MacEachen Institute for Public Policy and Governance; Medical Student, Dalhousie University
-
Lecturer in Psychology and Human Neuroscience, Royal Holloway
-
Ethical, Legal & Social Adviser - Public Health Genomics, Monash University
-
Professor of English, York University, Canada
-
PhD Candidate, School of Law, Trinity College Dublin
-
Associate Professor of Community Health Sciences, Boston University
-
Assistant Professor, University of South Florida
-
Research Fellow, University of Exeter
-
Assistant Professor of Family Medicine, University of Pittsburgh
